Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Hand (New York, N.Y.)|June 24, 2017
Preoperative Epoxy Embolization Facilitates the Safe and Effective Resection of Venous Malformations in the Hand and ForearmBrian P Holly, Yuval A Patel, James Park, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2002
An examination of factors predicting prioritization for liver transplantationAndrew J Muir, Linda L Sanders, Michael A Heneghan, et al.
AIDS and Behavior|December 31, 2010
An interrupted time series evaluation of a hepatitis C intervention for persons with HIVRae Jean Proeschold-Bell, Bettina Hoeppner, Baishakhi Taylor, et al.
AIDS Patient Care and Stds|August 7, 2012
Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfectionBrianna L Norton, Lawrence Park, Leah J McGrath, et al.
Alcohol, Clinical & Experimental Research|June 26, 2024
Psychological processes and alcohol reduction in patients with chronic hepatitis C: Results from the HepART trialDonna M Evon, Jia Yao, Catherine Zimmer, et al.
Transplantation Direct|December 21, 2020
Need for Pretransplant Midodrine Does Not Negatively Impact Simultaneous Liver-kidney Transplant OutcomesPranab M Barman, Lindsay Y King, Carl L Berg, et al.
Annals of Transplantation|August 3, 2016
Ammonia Level and Mortality in Acute Liver Failure: A Single-Center ExperienceAshwini M Niranjan-Azadi, Filiz Araz, Yuval A Patel, et al.
Open Forum Infectious Diseases|January 9, 2018
Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV InfectionLauren F Collins, Austin Chan, Jiayin Zheng, et al.
The American Journal of Hospice & Palliative Care|June 12, 2026
Evidence-Based Frameworks Increase Engagement in Serious Illness Communication Conversations for Patients With CirrhosisCristal Brown, Tyberius Ford, Rabecca Hernandez, et al.
Journal of Hepatology|May 20, 2008
Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patientsEric Lawitz, Maribel Rodriguez-Torres, Andrew J Muir, et al.
Pageof 19